Biomedical research network Refbio closes first cycle with stronger cross-border collaboration

16 03 2015


  • The members of the network are holding the project’s final event on 24 March in Pamplona to analyse the results, sign agreements to ensure their sustainability and talk about the future of the project.
  • The event includes a keynote speech by prestigious virologist Luis Enjuanes (CSIC), called “Emerging Viruses: Coronavirus and Ebola”.


Refbio, the Trans-Pyrenean Biomedical Research Network, which was created with the aim of promoting cooperation in health sciences on both sides of the Pyrenees, has completed its first cycle successfully and is holding an event on 24 March in Pamplona to assess the main results obtained since it was created in June 2012.

The event will start at 9.30 am at the headquarters of Navarrabiomed-Miguel Servet Foundation, the institution that is leading the project. It will be chaired by the Regional Minister of Health of Navarre, Marta Vera. It will also be attended by José María Roig, Director of Navarrabiomed, and the people in charge of the eight institutions that make up the network.

Cooperation agreements will be signed during the event, in order to ensure the sustainability of Refbio, and several of the projects developed within the network’s ten areas of strategic interest (such as oncology, cardiovascular system and neuroscience, amongst others) will be presented.


Keynote speech

To round off the event, the Director of the Coronavirus Laboratory at the CSIC’s National Centre for Biotechnology (CNB), Luis Enjuanes, will give a presentation called “Emerging Viruses: Coronavirus and Ebola”.

Mr Enjuanes, who is a renowned virologist, was part of the team of experts who advised the Spanish government during the recent Ebola crisis. He has also been a World Health Organisation (WHO) consultant, a member of the Gregorio Marañon Research Institute, and a professor at the Autonomous University of Madrid, and he has occupied many other important positions in various organisations.
About Refbio

The main objective of Refbio, the Trans-Pyrenean Biomedical Research Network, is to promote competitive research in the fields of oncology, haematology, cell therapy, neuroscience, epidemiology and public health, cardiovascular, infectious diseases and clinical trials.

The network is led by Navarrabiomed-Miguel Servet Foundation and is made up of the following organisations: Institute National de la Santé et de la Recherche Médicale (INSERM) from the Midi Pyrénées Limousin, Aragon Health Sciences Institute (IACS), Université Paul Sabatier de Toulouse, (UPS), Centre Hospitalier Universitaire de Toulouse (CHU), Basque Foundation for Health Innovation and Research (BIOEF), Center for Biomedical Research of La Rioja (CIBIR) and the Health Research Institute (BIODONOSTIA).

Set up in 2012, the Refbio project is part of the France-Spain-Andorra Territorial Operational Programme (POCTEFA), as part of the Pyrenean strategy to create a cross-border framework for cooperation in health.

Over the past two and a half years, Refbio has held several joint work sessions and specialised workshops, has established common areas of interest and has set up 17 research projects.